Integrated Filing — IndAS



General information about company

Scrip Code 507779
NSE Symbol KANPRPLA
MSEI Symbol NOTLISTED
ISIN INE694E01014
Name of company Kanpur Plastipack Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 04-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-01-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 04-02-2026   16:30:00
End date and time of board meeting 04-02-2026   18:40:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 19,170.01 53,864.06
Other income 352.69 492.31
Total income 19,522.70 54,356.37
2 Expenses
(a) Cost of materials consumed 7,533.80 24,451.12
(b) Purchases of stock-in-trade 4,632.32 9,692.03
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 737.37 467.46
(d) Employee benefit expense 1,994.51 5,376.81
(e) Finance costs 249.70 897.49
(f) Depreciation, depletion and amortisation expense 306.87 910.38
(f) Other Expenses
1 Other Expenses 2,842.26 9,399.04
Total other expenses 2,842.26 9,399.04
Total expenses 18,296.83 51,194.33
3 Total profit before exceptional items and tax 1,225.87 3,162.04
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,225.87 3,162.04
6 Tax expense
7 Current tax 286.24 778.18
8 Deferred tax 20.49 17.73
9 Total tax expenses 306.73 795.91
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 919.14 2,366.13
12 Profit (loss) from discontinued operations before tax 4.95 (181.73)
13 Tax expense of discontinued operations 1.25 (45.74)
14 Net profit (loss) from discontinued operation after tax 3.70 (135.99)
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 922.84 2,230.14
17 Other comprehensive income net of taxes 0.00 0.00
18 Total Comprehensive Income for the period 922.84 2,230.14
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 2,401.95 2,401.95
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.9 10.18
Diluted earnings (loss) per share from continuing operations 3.9 10.18
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0.02 -0.58
Diluted earnings (loss) per share from discontinued operations 0.02 -0.58
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.92 9.6
Diluted earnings (loss) per share from continuing and discontinued operations 3.92 9.6
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results of the Company were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 04.02.2026 and a Limited Review was carried by the Statutory Auditors of the Company. 2. The figures of previous period/year have been re-grouped/ re-arranged and /or recast wherever found necessary. 3. The EPS has been calculated on the basis of Weighted Average Number of Shares outstanding in the given year. 4. As per the in-principle approval of the Stock Exchanges (BSE and NSE) dated 20.10.2025, the company has allotted 3,33,700 equity shares to Mr. Manoj Agarwal (Promoter and Chairman cum Managing Director of the company) on 01.11.2025 against the acquisition of 76.19% holding of M/s. Valex Ventures Limited (UK). Listing of these shares has been obtained on 20.01.2026. Consequently, Valex Ventures Limited has become the subsidiary company . 5.As per principle approval of the stock exchanges (NSE and BSE) dated 31.07.2025, the company had allotted 1012000 warrants duly convertible into equity shares. Further on 09.12.2025 the company had converted 4,52,000 into equity shares. Listing of 4,52,000 equity shares is under process.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Manufacturing Division 14,783.71 44,315.80
2 Trading Division 4,738.99 10,040.57
Total Segment Revenue 19,522.70 54,356.37
Less: Inter segment revenue 0.00 0.00
Revenue from operations 19,522.70 54,356.37
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Manufacturing Division 1,391.18 3,776.57
2 Trading Division 84.39 282.96
Total Profit before tax 1,475.57 4,059.53
i. Finance cost 249.70 897.49
ii. Other Unallocable Expenditure net off Unallocable income 0.00 0.00
Profit before tax 1,225.87 3,162.04
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Manufacturing Division 42,374.41 42,374.41
2 Trading Division 1,492.79 1,492.79
Total Segment Asset 43,867.20 43,867.20
Un-allocable Assets 0.00 0.00
Net Segment Asset 43,867.20 43,867.20
4 Segment Liabilities
Segment Liabilities
1 Manufacturing Division 18,608.18 18,608.18
2 Trading Division 611.49 611.49
Total Segment Liabilities 19,219.67 19,219.67
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 19,219.67 19,219.67
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Manufacturing - It includes FIBC( Flexible Intermediate Bulk Containers), Fabrics, MFY (Multi Filament Yarn), CPP etc. CPP division of the company was closed w.e.f. 07.05.2025. Trading- It includes Granules Trading, commission from IOCL etc.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 09-12-2025
Amount Raised 4,06,80,000.00
Report filed for Quarter ended 31-12-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review Noted
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment of Borrowings NA 4,06,80,000.00 0.00 4,06,80,000.00 0.00


Signatory Details

Name of signatory Ankur Srivastava
Designation of person Company Secretary and Compliance Officer
Place Kanpur
Date 04-02-2026